Ipamorelin Dosage: What the Evidence Says (2026)
Not FDA-approved
Ghrelin-receptor agonist. Failed a phase 2 trial; not approved and not compoundable.
Regulatory status (US)
Not approved by the FDA for any use. Its nomination for pharmacy compounding was withdrawn, so it is on none of FDA's 503A lists and is not covered by the October 2026 HHS draft policy. In practice that means no legal US source for human use. It also remains on the FDA's significant-risk list for outsourcing facilities (503B), where IV use was linked to serious adverse events.
What it is
A five-amino-acid peptide that activates the ghrelin (growth hormone secretagogue) receptor.
Dosage
Ipamorelin reconstitution calculator
Enter your vial and your prescribed dose to see the units on a U-100 syringe.
What human studies show
- Phase 2 in post-surgery bowel recovery: 0.03 mg/kg by IV twice daily for up to 7 days in 114 patients. It did not work better than placebo.
Safety
- No approved dose for any use.
Questions
- Is Ipamorelin FDA-approved?
- Not approved by the FDA for any use. Its nomination for pharmacy compounding was withdrawn, so it is on none of FDA's 503A lists and is not covered by the October 2026 HHS draft policy. In practice that means no legal US source for human use. It also remains on the FDA's significant-risk list for outsourcing facilities (503B), where IV use was linked to serious adverse events.
- What dose of Ipamorelin has been studied?
- There is no established human dose. Phase 2 in post-surgery bowel recovery: 0.03 mg/kg by IV twice daily for up to 7 days in 114 patients. It did not work better than placebo.
- How many units is my Ipamorelin dose?
- Divide the mg in the vial by the mL of bacteriostatic water to get mg/mL, divide your dose in mg by that, and multiply by 100 for units on a U-100 syringe. The calculator on this page does it and draws the syringe.
Related
The first 29 amino acids of GHRH. Former brand Geref was withdrawn in 2009; no product is marketed today.
BPC-15715-amino-acid peptide studied mostly in animals. Not approved; no established human dose.
TB-500 (thymosin beta-4)Name used for thymosin beta-4 and for a 7-amino-acid fragment of it. Not approved; no human dose data for the fragment.
GHK-Cu (copper peptide)Copper-binding tripeptide used in skin care. Topical studies only; no human injection data.
Sources
- Beck et al. 2014: Ipamorelin in postoperative ileus, phase 2 (PubMed)
- FDA: 503A bulk drug substance categories (updated May 14, 2026, PDF)
- FDA 510(k) K212499: BD insulin syringes for U-100 insulin
Last checked 2026-11-16. How we pick and check sources: methodology.